Drug intelligence / Profile preview

Ertong Qingfei

Development stage
Unknown
Lead developer
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Ertong Qingfei is a Traditional Chinese Medicine (TCM) preparation developed by the First Teaching Hospital of Tianjin University of Chinese Medicine, specifically formulated for pediatric respiratory ailments. It is primarily indicated for the treatment of bronchial asthma and acute upper respiratory tract infections (URTI) in children. The formulation is designed to clear heat, ventilate the lungs, and resolve phlegm, which translates pharmacologically to anti-inflammatory, antitussive, and bronchodilatory activities. It typically contains a complex mixture of herbal extracts, often including *Ephedra sinica*, *Scutellaria baicalensis*, and *Armeniaca sibirica*. These components work synergistically to alleviate symptoms such as fever, cough with yellow sputum, and shortness of breath. As an in-hospital preparation, it is a staple in the clinical management of pediatric respiratory distress within the developing institution.

Brand names
Ertong Qingfei KoufuyeErtong Qingfei Wan
Other names
Children's Lung-Clearing Oral LiquidChildren's Lung-Clearing FormulaErtong Qingfei Mixture
02

Targets

ADRB2 (β2)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Ertong Qingfei.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ertong Qingfei.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call